Sarcoidosis: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• TNF 0
• CTLA-4 0
• TTR 0
• BCMA 0
• HMGB1 0
• IL-13 0
• IL-17 0
• LAG-3 0
• MAPK 0
• PD-1 0

EU-13 is a filter, not a ranking: it only narrows the list.

No research groups match this view yet.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  [68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation

  NCT05499637· John O. Prior· Updated 13 Oct 2026

  “Recruitment difficulties”Registry text, quoted unchanged. Source

• Terminated

  Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis

  NCT04758650· Universitair Ziekenhuis Brussel· Updated 1 Jun 2026

  “Delay in recruitment”Registry text, quoted unchanged. Source

• Terminated

  Use of CXCL9 as a Biomarker of Acthar Efficacy

  NCT02523092· University of California, San Francisco· Updated 30 Apr 2026

  “sponsor closed study down”Registry text, quoted unchanged. Source

• Terminated

  A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis

  NCT05314517· Kinevant Sciences GmbH· Updated 12 Sept 2025

  “Sponsor Decision”Registry text, quoted unchanged. Source

• Withdrawn

  Tyrosine Kinase 2 (TYK2) for GA and CS

  NCT06725264· Yale University· Updated 29 Apr 2025

  “Funding was rescinded.”Registry text, quoted unchanged. Source

• Withdrawn

  Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis

  NCT05910554· University of Maryland, Baltimore· Updated 11 Feb 2025

  “Many of sarcoidosis patients in this area already taking metformin”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Clinical Trial of Tulisokibart (MK-7240) in Participants With Pulmonary Sarcoidosis (MK-7240-016)

  NCT07867938· Merck Sharp & Dohme LLC· Source

• Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD

  NCT07859839· Post Graduate Institute of Medical Education and Research, Chandigarh· Source

• Vitamin D Homeostasis in Sarcoidosis

  NCT03621553· University of Texas Southwestern Medical Center· Source

• Interstitial Lung Disease Research Unit Biobank

  NCT05392881· University of Kansas Medical Center· Source

• A Study of the Natural Progression of Interstitial Lung Disease (ILD)

  NCT00470327· University of Chicago· Source

• A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

  NCT06025578· Bristol-Myers Squibb· Source

• Cardiac Imaging in Systemic Disorders: the ORACLES Registry

  NCT07134166· Assistance Publique - Hôpitaux de Paris· Source

• Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases

  NCT04924270· Odense University Hospital· Source

• CZI Rare As One: Co-designing an App and Wearable Based Compass for Rare Diseases

  NCT06907953· 4YouandMe· Source

• Evaluation of the Impact of a Patient Education Protocol on the Quality of 18F-FDG PET Imaging Indicated for Investigation of Cardiac Inflammation

  NCT07029295· Assistance Publique - Hôpitaux de Paris· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 2
• Mendelian Randomization Analysis 3
• Gene Expression Profiling 3
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 2
• Proteomics 7
• Metabolomics 3
• Flow Cytometry 2
• Immunohistochemistry 3
• Positron-Emission Tomography 34
• Magnetic Resonance Imaging 41
• Machine Learning 3
• Cohort Studies 10
• Genome-Wide Association Study 4

• Sarcoidosis data-driven patient trajectories and predictors of chronic disease.

  Respir Res, Jul 2026

• Positive Endomyocardial Biopsy in Cardiac Sarcoidosis: Predictors and Outcomes From the Japanese ILLUMINATE-CS (Illustration of the Management and prognosis of JapaNese PATiEnts with Cardiac Sarcoidosis) Registry.

  J Card Fail, May 2026

• Immune-Mediated Inflammatory Diseases Following Pediatric Uveitis Diagnosis.

  JAMA Netw Open, May 2026

• The Mediating Effect of Inflammatory Biomarkers in the Associations Between Sarcoidosis and Incident Ischemic Stroke: A Prospective Cohort Study.

  Brain Behav, Apr 2026

• Radiomic profiling of chest CT in a cohort of sarcoidosis cases.

  Sci Rep, Feb 2026

• Clinical features, treatment strategies, and long-term outcomes of Blau syndrome: a 10-year experience from a Chinese cohort.

  Adv Rheumatol, Feb 2026

• Neurosarcoidosis of the hypothalamus, infundibulum, and pituitary gland: A retrospective cohort study.

  J Neurol Sci, Feb 2026

• A retrospective multicenter cohort study of patients with sarcoidosis and renal involvement.

  BMC Nephrol, Jan 2026

• The Role of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Sarcoid Cardiomyopathy: A Multicenter Retrospective Cohort Study.

  Am J Cardiovasc Drugs, Dec 2025

• Matrix metalloproteinases and disease severity among PI*MZ and PI*ZZ individuals in the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) cohort.

  BMJ Open Respir Res, Nov 2025

See which targets of this disease your abstract mentions, and go to the people working on them.